首页> Molecular and clinical oncology> Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.

导出 LinkOut

翻译打印收藏纠错

第一作者： Francesco,Schettini

第一单位： Department of Clinical Medicine and Surgery, University of Naples 'Federico II', I-80131 Naples, Italy.;Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, 08036 Barcelona, Spain.

作者： Francesco,Schettini ^[1] ; Irene De,Santo ^[2] ; Carmen G,Rea ^[3] ; Martina,Viggiani ^[3] ; Giuseppe,Buono ^[3] ; Carmine De,Angelis ^[3] ; Cinzia,Cardalesi ^[3] ; Rossella,Lauria ^[3] ; Mario,Giuliano ^[3] ; Valeria,Forestieri ^[3] ; Guglielmo,Thomas ^[4] ; Pierfrancesco,Maione ^[5] ; Gennaro,Limite ^[6] ; Antonello,Accurso ^[6] ; Luca,Malorni ^[7] ; Sabino De,Placido ^[3] ; Grazia,Arpino ^[3]

作者单位： Department of Clinical Medicine and Surgery, University of Naples 'Federico II', I-80131 Naples, Italy.;Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, 08036 Barcelona, Spain. ^[1] Department of Clinical Medicine and Surgery, University of Naples 'Federico II', I-80131 Naples, Italy.;'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, I-59100 Prato, Italy. ^[2] Department of Clinical Medicine and Surgery, University of Naples 'Federico II', I-80131 Naples, Italy. ^[3] Clinica Mediterranea, I-80100 Naples, Italy, Senology Unit, Villa Betania Hospital, I-80100 Naples, Italy. ^[4] Senology Unit, Villa Betania Hospital, I-80100 Naples, Italy. ^[5] Department of General and Specialist Surgery, University of Naples 'Federico II', I-80131 Naples, Italy. ^[6] 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, I-59100 Prato, Italy. ^[7]

关键词 breast cancer case report endocrine resistance endocrine sensitization endocrine therapy fulvestrant palbociclib

DOI 10.3892/mco.2020.2016

PMID 32257203

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Molecular and clinical oncology

2020年12卷5期

456-460页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Molecular and clinical oncology

2020年12卷5期

456-460页

检索历史清除

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.

Molecular and clinical oncology

相似文献

同项目论文

Molecular and clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series.

Molecular and clinical oncology

相似文献

同项目论文

Molecular and clinical oncology

相关期刊

检索历史清除